Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 18.73B 2.77B 2.39B 2.21B 2.06B 3.85B 263B 3.94B 26.21B 10.17B 128B 10.38B 10.16B 444B P/E ratio 2026 *
12.6x
P/E ratio 2027 * 11x
Enterprise value 15.21B 2.25B 1.94B 1.79B 1.68B 3.13B 214B 3.2B 21.29B 8.26B 104B 8.43B 8.25B 360B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.45x
Free-Float
34.77%
Yield 2026 *
5.36%
Yield 2027 * 5.68%
1 day+3.85%
1 week+1.61%
Current month-0.30%
1 month-11.32%
3 months-14.72%
6 months-5.73%
Current year-6.64%
1 week 15.57
Extreme 15.57
16.49
1 month 15.34
Extreme 15.34
18.88
Current year 15.34
Extreme 15.34
21.78
1 year 15.34
Extreme 15.34
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 27/02/2019
Director of Finance/CFO 44 09/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 15/07/2013
Director/Board Member 63 07/08/2016
Chairman 48 27/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
+3.85%+1.61%-2.08%-38.71% 2.66B
-1.32%-0.11%-7.80%-23.98% 15.15B
-2.59%-5.04%-26.30%-29.23% 7.14B
-1.07%+3.44%-15.50%-10.09% 5.79B
+2.13%+5.07%-17.62%-27.14% 3.7B
+0.59%+0.32%-37.91%-9.58% 3.32B
-0.16%-1.80%-20.41%-44.76% 3.31B
+0.33%+7.23%+103.44% - 2.65B
-0.38%-2.09%-25.60%-6.16% 2.57B
+0.58%+0.58%+2.16%+38.46% 1.69B
Average +0.20%+0.08%-4.76%-16.80% 4.8B
Weighted average by Cap. -0.50%-2.37%-9.33%-21.28%

Financials

2026 *2027 *
Net sales 29.97B 4.42B 3.83B 3.53B 3.3B 6.16B 421B 6.3B 41.93B 16.26B 204B 16.6B 16.25B 710B 33.01B 4.87B 4.22B 3.89B 3.64B 6.79B 464B 6.94B 46.19B 17.91B 225B 18.29B 17.9B 782B
Net income 1.48B 219M 190M 175M 164M 305M 20.88B 312M 2.08B 806M 10.11B 823M 805M 35.16B 1.7B 251M 217M 200M 188M 350M 23.94B 358M 2.38B 924M 11.59B 943M 923M 40.31B
Net Debt -3.52B -519M -450M -414M -388M -724M -49.48B -740M -4.92B -1.91B -23.96B -1.95B -1.91B -83.34B -4.01B -592M -512M -472M -442M -824M -56.38B -843M -5.61B -2.18B -27.31B -2.22B -2.17B -94.96B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
10/06/26 16.45 ¥ +3.85% 6,503,179
09/06/26 15.84 ¥ +0.32% 5,742,741
08/06/26 15.79 ¥ -0.88% 6,087,934
05/06/26 15.93 ¥ -0.93% 6,286,822
04/06/26 16.08 ¥ -0.68% 4,156,636
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
16.45CNY
Average target price
24.49CNY
Spread / Average Target
+48.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!